For personal use only

Market Announcement
9 July 2020

Race Oncology Ltd (ASX: RAC) – Trading Halt
Description
The securities of Race Oncology Ltd (‘RAC’) will be placed in trading halt at the request of RAC, pending it
releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the
earlier of the commencement of normal trading on Monday, 13 July 2020 or when the announcement is
released to the market.

Issued by
Isabelle Andrews
Senior Adviser, Listings Compliance (Perth)

9 July 2020
ASX Limited

Market Announcement 1/1
ASX Customer Service Centre 131 279 | asx.com.au

For personal use only

9 July 2020
Mr Sean Maloney
Adviser, Listings Compliance (Perth)
ASX Compliance Pty Ltd
Level 40 Central Park
152-158 St George’s Terrace
PERTH WA 6000
Via Email:
Sean.Maloney@asx.com.au
TradingHaltsPerth@asx.com.au
Dear Sean
TRADING HALT REQUEST
In accordance with ASX Listing Rule 17.1, Race Oncology Limited (the Company) hereby requests that
its securities be placed into an immediate trading halt.
For the purposes of Listing Rule 17.1, the Company provides the following information:
(a)

the trading halt is requested pending an announcement regarding a share placement to
strategic investors;

(b)

the Company requests that the trading halt remain in place until the earlier of the Company
making an announcement in relation to a share placement or until the market opens on
Monday, 13 July 2020; and

(c)

the Company is not aware of any reason why the trading halt should not be granted.

Authorised for release by the Board

Peter Webse
Company Secretary

Race Oncology Ltd ABN 61 149 318 749
Registered office: L40, 140 William St, Melbourne VIC Australia 3000
www.raceoncology.com

